Should morbidity replace mortality as an endpoint for clinical trials in intensive care?
about
A comparative analysis of predictive models of morbidity in intensive care unit after cardiac surgery - part I: model planning.Impact of immunomodulating therapy on morbidity in patients with severe sepsis.A multivariate Bayesian model for assessing morbidity after coronary artery surgery.Daily estimation of the severity of organ dysfunctions in critically ill children by using the PELOD-2 scoreMorbidity associated with Pseudomonas aeruginosa bloodstream infections.Acute hypoxemic respiratory failure in children: case mix and the utility of respiratory severity indices.SOFA and mortality endpoints in randomized controlled trials: a systematic review and meta-regression analysis.Risk factors associated with unfavorable short-term treatment outcome in patients with documented Pseudomonas aeruginosa infection.Daily estimation of the severity of multiple organ dysfunction syndrome in critically ill children.Inhaled vasodilator therapy in acute lung injury: first, do NO harm?Maternal outcome in HELLP syndrome requiring intensive care management in a Turkish hospital.Inhaled nitric oxide in acute respiratory distress syndrome: a pilot randomized controlled study.Development of a pediatric multiple organ dysfunction score: use of two strategies.The Impact of Qualitative Respiratory Cultures on Mortality in Critically III Patients with Hospital-Acquired PneumoniaTime course of organ failure in patients with septic shock treated with hydrocortisone: results of the Corticus study
P2860
Q33306988-F985F0F5-2B31-4DDC-A959-EE51CCC06B38Q33872936-8BE9AB73-D69D-44CD-9613-43943BCEEDB2Q34999651-645431B4-F942-4D24-9FA2-51FA237794DBQ36060518-629C054E-6275-4E24-A8E8-6C63C10A816EQ37219943-E50C4C5A-EB07-4625-B576-17F7B4CB61ACQ38462253-E52E8737-11E2-4B96-990C-691743E9636BQ38753960-7084F0B7-7999-48E2-8AE8-AE62F372EC17Q41512238-F54A4504-3D94-47BA-82AF-9D3C157A300FQ42154598-B58FA66B-8A07-481C-A80E-75BA5E89F333Q42416175-5724CD0F-8B84-47C5-BFFF-B155845C0BD5Q46341335-FDF2C9F9-21A1-47B7-9CDF-C24A50C957A6Q51519767-687314ED-064D-4C46-B9ED-65DCDBB3647DQ52173974-C2537122-B78C-4F33-8CE6-6DCE4FB1EF79Q57779747-63A199C4-3F01-45AF-B495-B4D8C61C3EB1Q58415983-1F03FC3B-05F7-4EAB-BF4B-521D6370B3CC
P2860
Should morbidity replace mortality as an endpoint for clinical trials in intensive care?
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh-hant
name
Should morbidity replace mortality as an endpoint for clinical trials in intensive care?
@en
Should morbidity replace mortality as an endpoint for clinical trials in intensive care?
@nl
type
label
Should morbidity replace mortality as an endpoint for clinical trials in intensive care?
@en
Should morbidity replace mortality as an endpoint for clinical trials in intensive care?
@nl
prefLabel
Should morbidity replace mortality as an endpoint for clinical trials in intensive care?
@en
Should morbidity replace mortality as an endpoint for clinical trials in intensive care?
@nl
P2093
P1433
P1476
Should morbidity replace mortality as an endpoint for clinical trials in intensive care?
@en
P2093
A J Petros
H K van Saene
J C Marshall
P304
P356
10.1016/S0140-6736(95)90347-X
P407
P577
1995-02-01T00:00:00Z